Literature DB >> 19648390

Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline.

J Taylor Hays1, Jon O Ebbert, Amit Sood.   

Abstract

Cigarette smoking is the most important preventable cause of morbidity, mortality, and excess health care costs in the United States. From 2000 through 2004, cigarette smoking caused an estimated annual average of 443,595 deaths and cost $193 billion per year in smoking-attributable productivity losses and smoking-related health care expenditures. Preventing smoking and providing effective treatment to help smokers quit will remain a public health priority for the foreseeable future. In support of this goal, the US Department of Health and Human Services recently published the clinical practice guideline entitled Treating Tobacco Use and Dependence: 2008 Update. The new guideline updates the previous guidelines published in 1996 and 2000 and presents many new research findings to provide a broader evidence base for effective intervention. This article briefly reviews the major updates and recommendations from the new guideline and highlights its practical clinical applications.

Entities:  

Mesh:

Year:  2009        PMID: 19648390      PMCID: PMC2719526          DOI: 10.1016/S0025-6196(11)60523-5

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  24 in total

1.  The long-term effect of nicotine on the oral mucosa.

Authors:  M Wallström; L Sand; F Nilsson; J M Hirsch
Journal:  Addiction       Date:  1999-03       Impact factor: 6.526

2.  Cigarette smoking among adults--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-11-14       Impact factor: 17.586

Review 3.  Bupropion sustained release and smoking cessation.

Authors:  M G Goldstein
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 4.  Nicotine medications for smoking cessation.

Authors:  J E Henningfield
Journal:  N Engl J Med       Date:  1995-11-02       Impact factor: 91.245

Review 5.  Antidepressants for smoking cessation.

Authors:  J Hughes; L Stead; T Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

6.  Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.

Authors: 
Journal:  Arch Intern Med       Date:  1994-05-09

7.  Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000.

Authors:  Andrew Boshier; Lynda V Wilton; Saad A W Shakir
Journal:  Eur J Clin Pharmacol       Date:  2003-11-13       Impact factor: 2.953

Review 8.  Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits.

Authors:  J Taylor Hays; Jon O Ebbert
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial.

Authors:  Gary E Swan; Tim McAfee; Susan J Curry; Lisa M Jack; Harold Javitz; Sara Dacey; Katherine Bergman
Journal:  Arch Intern Med       Date:  2003-10-27

Review 10.  Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease.

Authors:  Anne M Joseph; Steven S Fu
Journal:  Prog Cardiovasc Dis       Date:  2003 May-Jun       Impact factor: 8.194

View more
  8 in total

Review 1.  A thematic analysis of theoretical models for translational science in nursing: mapping the field.

Authors:  Sandra A Mitchell; Cheryl A Fisher; Clare E Hastings; Leanne B Silverman; Gwenyth R Wallen
Journal:  Nurs Outlook       Date:  2010 Nov-Dec       Impact factor: 3.250

2.  Feasibility of using a standardized patient encounter for training chiropractic students in tobacco cessation counseling.

Authors:  Cheryl Hawk; Martha A Kaeser; David V Beavers
Journal:  J Chiropr Educ       Date:  2013-06-27

3.  Predictors of quit attempts and successful quit attempts in a nationally representative sample of smokers.

Authors:  Claudia Rafful; Olaya García-Rodríguez; Shuai Wang; Roberto Secades-Villa; Jose M Martínez-Ortega; Carlos Blanco
Journal:  Addict Behav       Date:  2013-01-04       Impact factor: 3.913

4.  Identification of a new selective dopamine D4 receptor ligand.

Authors:  Dinithia Sampson; Xue Y Zhu; Suresh V K Eyunni; Jagan R Etukala; Edward Ofori; Barbara Bricker; Nazarius S Lamango; Vincent Setola; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2014-04-20       Impact factor: 3.641

5.  Impact of Broadened Coverage of Smoking Cessation Treatments on Cardiovascular Disease.

Authors:  Paul A Fishman
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-12-01

6.  Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.

Authors:  Hasmeena Kathuria; Frank C Detterbeck; Joelle T Fathi; Kathleen Fennig; Michael K Gould; Denise G Jolicoeur; Stephanie R Land; Greta M Massetti; Peter J Mazzone; Gerard A Silvestri; Christopher G Slatore; Robert A Smith; Anil Vachani; Steven B Zeliadt; Renda Soylemez Wiener
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 30.528

7.  Helping cancer patients quit smoking using brief advice based on risk communication: A randomized controlled trial.

Authors:  William H C Li; M P Wang; K Y Ho; Katherine K W Lam; Derek Y T Cheung; Yannes T Y Cheung; T H Lam; Sophia S C Chan
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

8.  Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.

Authors:  Tatsuya Nagano; Masahiro Katsurada; Yuichiro Yasuda; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.